Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

Completed · Phase 1

Conditions studied: Obstetric Labour, Premature, Premature Labor

In brief

This is a phase one study investigating the absorption, distribution, metabolism and excretion of GSK221149A in six healthy women of non-child bearing potential.

Key facts

Study ID

NCT00457925

Run by

GlaxoSmithKline

People needed

6

Starts

2006-10-01

Last updated by the study team

2012-03-19

Who can join

Age: 30 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy adult, non-smoking females
• Aged between 30 - 55 years old, and BMI of between 19 and 32
• Not of child-bearing potential

You may not qualify if…

• No clinically significant findings on clinical examination, medical examination and blood tests.
• Radiation exposure over previous 3 years is greater than 10mSv
• History of bleeding or gastric problems

Where it is running

• GSK Investigational Site — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.